Title : [Relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients].

Pub. Date : 2011 Apr

PMID : 21496433






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND AND OBJECTIVE: It has been proven that ribonucleotide reductase M1 (RRM1) expression level was closely related to gemcitabine drug-resistance to tumor cells. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens
2 BACKGROUND AND OBJECTIVE: It has been proven that ribonucleotide reductase M1 (RRM1) expression level was closely related to gemcitabine drug-resistance to tumor cells. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens
3 The aim of this study is to explore the relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens
4 CONCLUSIONS: RRM1 protein expression levels are closely related to effects of gemcitabine and cisplatin chemotherapy and prognosis of advanced NSCLC patients. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens